A Multicentric, Non-interventional Study on Switching From Oral Parkinson Therapy to Neupro® in Patients With Idiopathic Parkinson's Disease With Gastrointestinal Symptoms

Trial Profile

A Multicentric, Non-interventional Study on Switching From Oral Parkinson Therapy to Neupro® in Patients With Idiopathic Parkinson's Disease With Gastrointestinal Symptoms

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Mar 2015

At a glance

  • Drugs Rotigotine (Primary)
  • Indications Parkinson's disease
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms NON-GI
  • Sponsors UCB
  • Most Recent Events

    • 19 Mar 2013 Results have been presented at the 65th American Academy of Neurology Annual Meeting (AAN-2013) according to a UCB media release. Results were also summarised in the media release.
    • 30 Apr 2012 Actual patient number is 76 according to ClinicalTrials.gov.
    • 27 Apr 2012 Actual end date (Mar 2012) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top